The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

作者: Mukesh Verma

DOI: 10.1007/978-94-017-7215-0_5

关键词:

摘要: Epigenetics plays a key role in cancer development. Genetics alone cannot explain sporadic and development individuals with no family history or weak of cancer. provides mechanism to the such situations. Alterations epigenetic profiling may provide important insights into etiology natural Because several changes occur before histopathological changes, they can serve as biomarkers for diagnosis risk assessment. Many cancers remain asymptomatic until relatively late stages; managing disease, efforts should be focused on early detection, accurate prediction disease progression, frequent monitoring. This chapter describes are expressed during their potential use prognosis. Based epigenomic information, have been identified that diagnostic tools; some also useful identifying who will respond therapy survive longer. The importance analytical clinical validation is discussed, along challenges opportunities this field.

参考文章(235)
Theoni Trangas, Sotirios Sotiriou, Aikaterini Apostolaki, Stamatia Velaeti, Theodoros Kalogeropoulos, Michalis Synesiou, Vasilios Klapsas, Loukas Fasoulis, Evangelos Vassiliou, Nikolaos Pandis, Efthymios Dimitriadis, Study of Genetic and Epigenetic Alterations in Urine Samples as Diagnostic Markers for Prostate Cancer Anticancer Research. ,vol. 33, pp. 191- 197 ,(2013)
Mukesh Verma, Epigenetic biomarkers in cancer epidemiology. Methods of Molecular Biology. ,vol. 863, pp. 467- 480 ,(2012) , 10.1007/978-1-61779-612-8_28
Mukesh Verma, Sudhir Srivastava, New cancer biomarkers deriving from NCI early detection research. Recent results in cancer research. ,vol. 163, pp. 72- 84 ,(2003) , 10.1007/978-3-642-55647-0_7
Mukesh Verma, Daniela Seminara, Fernando J. Arena, Christy John, Kumiko Iwamoto, Virginia Hartmuller, Genetic and Epigenetic Biomarkers in Cancer Molecular Diagnosis & Therapy. ,vol. 10, pp. 1- 15 ,(2006) , 10.1007/BF03256438
Vincent L Biron, Adil Mohamed, Michael J Hendzel, D Alan Underhill, Seikaly H, None, Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas. Journal of Otolaryngology-head & Neck Surgery. ,(2012)
Sharad Khare, Mukesh Verma, Epigenetics of colon cancer. Methods of Molecular Biology. ,vol. 863, pp. 177- 185 ,(2012) , 10.1007/978-1-61779-612-8_10
Mukesh Verma, Proteomics and Cancer Epidemiology Methods of Molecular Biology. ,vol. 471, pp. 197- 215 ,(2009) , 10.1007/978-1-59745-416-2_10
Young Kyoon Kim, Wun-Jae Kim, Epigenetic markers as promising prognosticators for bladder cancer International Journal of Urology. ,vol. 16, pp. 17- 22 ,(2009) , 10.1111/J.1442-2042.2008.02143.X
Fung‐Yu Huang, Annie On‐On Chan, Asif Rashid, Danny Ka‐Ho Wong, Chi‐Hin Cho, Man‐Fung Yuen, None, Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells. Cancer. ,vol. 118, pp. 4969- 4980 ,(2012) , 10.1002/CNCR.27519
Qi‐Ming Yu, Xin‐Bao Wang, Jun Luo, Shi Wang, Xian‐Hua Fang, Jiang‐Liu Yu, Zhi‐Qiang Ling, CDH1 Methylation in Preoperative Peritoneal Washes Is an Independent Prognostic Factor for Gastric Cancer Journal of Surgical Oncology. ,vol. 106, pp. 765- 771 ,(2012) , 10.1002/JSO.23116